Fast Market Research recommends "Healthcare, Regulatory and Reimbursement Landscape - Nigeria" from GlobalData, now available

Boston, MA -- (SBWire) -- 12/19/2012 --GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Nigeria". An essential source of information and analysis on the Nigerian healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2011, Nigeria's population reached 167 million, largely due to increased life expectancy and the high proportion of teenage pregnancies. The mortality rate has been decreasing due to increased funding in the healthcare sector by the government and the initiation of healthcare campaigns throughout the country. The pharmaceutical market was estimated at $774m in 2010, and is expected to reach $2.08 billion by 2020, at a projected CAGR of 10%. The medical device market was worth approximately $214m in 2011.

View Full Report Details and Table of Contents

The positive trends in Nigeria's healthcare market can be attributed primarily to -

- Improving regulatory environment
- Increase in the number of healthcare facilities
- Increase in per capita income.

Scope

- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline, May and Baker Nigeria, Fidson Healthcare Plc, Emzor Pharmaceuticals Industries Ltd and Evans Medical Plc.
- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drugs and medical devices.
- Detailed analysis of Nigeria's political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to Get this Report

- Develop business strategies by understanding the trends shaping and driving the healthcare market in Nigeria.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments, and companies likely to impact the healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Healthcare, Regulatory and Reimbursement Landscape - Mexico
- Healthcare, Regulatory and Reimbursement Landscape Russia
- Healthcare, Regulatory and Reimbursement Landscape Vietnam
- Healthcare, Regulatory and Reimbursement Landscape - Brazil
- Healthcare, Regulatory and Reimbursement Landscape - China
- Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
- Healthcare, Regulatory and Reimbursement Landscape - India
- Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
- Healthcare, Regulatory and Reimbursement Landscape - Taiwan
- Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia